scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051513399 |
P356 | DOI | 10.1186/2051-1426-3-S2-O5 |
P932 | PMC publication ID | 4646122 |
P50 | author | Saad S. Kenderian | Q45896559 |
Marco Ruella | Q56947896 | ||
Simon F Lacey | Q56978267 | ||
Stephan A Grupp | Q104495066 | ||
David L. Porter | Q110797660 | ||
Carl H. June | Q19277113 | ||
P2093 | author name string | John Scholler | |
Christopher A Hunter | |||
Olga Shestova | |||
David M Barrett | |||
Farzana Nazimuddin | |||
Saar Gill | |||
Ted J Hofmann | |||
Jan J Melenhorst | |||
David A Christian | |||
Jessica Perazzelli | |||
P2860 | cites work | Chimeric antigen receptor T cells for sustained remissions in leukemia | Q29617588 |
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia | Q29617590 | ||
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study | Q34042800 | ||
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells | Q37697847 | ||
CD123 and its potential clinical application in leukemias. | Q38274851 | ||
P433 | issue | Suppl 2 | |
P921 | main subject | immunotherapy | Q1427096 |
P304 | page(s) | O5-O5 | |
P577 | publication date | 2015-11-04 | |
P1433 | published in | Journal for Immunotherapy of Cancer | Q27725163 |
P1476 | title | Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells | |
P478 | volume | 3 |
Search more.